Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nicholas D James

Showing results (11-20 of 197) with videos related to

Pageof 20
Sort By:
The New England Journal of Medicine|October 26, 2017
Abiraterone in Metastatic Prostate CancerNicholas D James, Melissa R Spears, Matthew R Sydes
BJU International|March 6, 2010
Osteoporosis in patients with prostate cancer on long-term androgen deprivation therapy: an increasing, but under-recognized problemJanet E Brown, Jennifer M Sherriff, Nicholas D James
BMJ (Clinical Research Ed.)|January 15, 2010
Osteoporosis and antiandrogens. An under-recognised riskJennifer M Sherriff, Janet E Brown, Nicholas D James
European Urology|October 11, 2016
Reply to Che-Kai Tsao, Matthew D. Galsky, and William K. Oh's Platinum Opinion. Docetaxel for Metastatic Hormone-Sensitive Prostate Cancer: Urgent Need To Minimize The Risk Of Neutropenic Fever. Eur Urol 2016;70:707-708Matthew R Sydes, Alastair W S Ritchie, Nicholas D James, et al.
Interactive Cardiovascular and Thoracic Surgery|April 29, 2011
Proteomic analysis of resectable non-small cell lung cancer: post-resection serum samples may be useful in identifying potential markersSridhar Rathinam, Douglas G Ward, Nicholas D James, et al.
Oncology Reports|July 3, 2010
Sunitinib in patients with metastatic renal cell carcinoma: Birmingham experienceJawaher Ansari, Arfeen Fatima, Kieran Fernando, et al.
Medical Decision Making : an International Journal of the Society for Medical Decision Making|July 26, 2015
A Practical Application of Value of Information and Prospective Payback of Research to Prioritize Evaluative ResearchLazaros Andronis, Lucinda J Billingham, Stirling Bryan, et al.
The Lancet. Neurology|September 29, 2018
Neuromodulation in the restoration of function after spinal cord injuryNicholas D James, Stephen B McMahon, Edelle C Field-Fote, et al.
Onkologie|February 12, 2009
Sorafenib induces therapeutic response in a patient with metastatic collecting duct carcinoma of kidneyJawaher Ansari, Arfeen Fatima, Shalini Chaudhri, et al.
European Urology|March 15, 2020
Reply to Wei Liu, Xiaoping Liu, Sheng Li's Letter to the Editor, re: Robert A. Huddart, Emma Hall, Rebecca Lewis, et al. Patient-reported Quality of Life Outcomes in Patients Treated for Muscle-invasive Bladder Cancer with Radiotherapy ± Chemotherapy in the BC2001 Phase III Randomised Controlled Trial. Eur Urol 2020;77:260-8Robert Huddart, Emma Hall, Rebecca Lewis, et al.
Pageof 20

Showing results (11-20 of 197) with videos related to

Sort By:
Pageof 20
The New England Journal of Medicine|October 26, 2017
Abiraterone in Metastatic Prostate CancerNicholas D James, Melissa R Spears, Matthew R Sydes
BJU International|March 6, 2010
Osteoporosis in patients with prostate cancer on long-term androgen deprivation therapy: an increasing, but under-recognized problemJanet E Brown, Jennifer M Sherriff, Nicholas D James
BMJ (Clinical Research Ed.)|January 15, 2010
Osteoporosis and antiandrogens. An under-recognised riskJennifer M Sherriff, Janet E Brown, Nicholas D James
European Urology|October 11, 2016
Reply to Che-Kai Tsao, Matthew D. Galsky, and William K. Oh's Platinum Opinion. Docetaxel for Metastatic Hormone-Sensitive Prostate Cancer: Urgent Need To Minimize The Risk Of Neutropenic Fever. Eur Urol 2016;70:707-708Matthew R Sydes, Alastair W S Ritchie, Nicholas D James, et al.
Interactive Cardiovascular and Thoracic Surgery|April 29, 2011
Proteomic analysis of resectable non-small cell lung cancer: post-resection serum samples may be useful in identifying potential markersSridhar Rathinam, Douglas G Ward, Nicholas D James, et al.
Oncology Reports|July 3, 2010
Sunitinib in patients with metastatic renal cell carcinoma: Birmingham experienceJawaher Ansari, Arfeen Fatima, Kieran Fernando, et al.
Medical Decision Making : an International Journal of the Society for Medical Decision Making|July 26, 2015
A Practical Application of Value of Information and Prospective Payback of Research to Prioritize Evaluative ResearchLazaros Andronis, Lucinda J Billingham, Stirling Bryan, et al.
The Lancet. Neurology|September 29, 2018
Neuromodulation in the restoration of function after spinal cord injuryNicholas D James, Stephen B McMahon, Edelle C Field-Fote, et al.
Onkologie|February 12, 2009
Sorafenib induces therapeutic response in a patient with metastatic collecting duct carcinoma of kidneyJawaher Ansari, Arfeen Fatima, Shalini Chaudhri, et al.
European Urology|March 15, 2020
Reply to Wei Liu, Xiaoping Liu, Sheng Li's Letter to the Editor, re: Robert A. Huddart, Emma Hall, Rebecca Lewis, et al. Patient-reported Quality of Life Outcomes in Patients Treated for Muscle-invasive Bladder Cancer with Radiotherapy ± Chemotherapy in the BC2001 Phase III Randomised Controlled Trial. Eur Urol 2020;77:260-8Robert Huddart, Emma Hall, Rebecca Lewis, et al.
Pageof 20